Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Oyster Point Pharma

3 Stocks to Buy With Less Than $10

The recent collapse of two banks and growing uncertainty about the Fed’s next rate hike amid the strong economic data releases fueled a broad market sell-off lately. However, a volatile market environment offers an attractive opportunity to invest in quality stocks ADT (ADT), Viatris (VTRS), and trivago (TRVG) at reasonable…

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022

Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday

Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday

U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

12 Health Care Stocks Moving In Monday's Intraday Session

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

12 Health Care Stocks Moving In Wednesday's Intraday Session

Oyster Point Outlines Restructuring Plan With Savings Of Up To $48M In 2023

Oyster Point Pharma Inc (NASDAQ:OYST) will implement an operating expense streamlining plan to reduce employee and non-employee expenses (up to 50 roles) across the organization. The company plans to continue to drive the launch of Tyrvaya with approximately 150-200 field-based sales resources. The plan is expected to reduce operating expenses by approximately $6…

inkl

Read news from The Economist, FT, and more,
with one subscription

Earnings Preview: Oyster Point Pharma

Earnings Preview: Oyster Point Pharma

Oyster Point Pharma (NASDAQ:OYST) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Oyster Point Pharma will report an earnings per share (EPS) of $-1.74.

People

106,481 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Williams-Sonoma

SolarEdge Technologies

Digital World Acquisition Corp

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

260,330 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play